Application Nr Approved Date Route Status External Links
NDA022127 2007-10-19 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Renvela® (sevelamer Carbonate) Is Indicated For The Control Of Serum Phosphorus In Patients With Chronic Kidney Disease (ckd) On Dialysis. Renvela® Is A Phosphate Binder Indicated For The Control Of Serum Phosphorus In Patients With Chronic Kidney Disease On Dialysis. (1)

All Formulated Excipients (2 Total)

Name Structure Kind Function Status
1. Diacetylated Monoglycerides DIACETYLATED MONOGLYCERIDES Unresolved
2. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sevelamer Carbonate SEVELAMER CARBONATE ZINC2016052

Comments